Role of prostaglandin E1 infusion in the management of transposition of the great arteries.

Suppr

超能文献

作者信息

Benson L N, Olley P M, Patel R G, Coceani F, Rowe R D

出版信息

Am J Cardiol. 1979 Oct;44(4):691-6. doi: 10.1016/0002-9149(79)90289-3.

DOI:10.1016/0002-9149(79)90289-3

PMID:484498

Abstract

摘要

相似文献

Role of prostaglandin E1 infusion in the management of transposition of the great arteries.

Am J Cardiol. 1979 Oct;44(4):691-6. doi: 10.1016/0002-9149(79)90289-3.

The use of prostaglandin E1 in a critically ill infant with transposition of the great arteries.前列腺素E1在一名患有大动脉转位的危重症婴儿中的应用。

J Pediatr. 1979 Aug;95(2):259-61.

Long-term low-dose prostaglandin E1 administration.长期低剂量前列腺素E1给药。

J Pediatr. 1980 Feb;96(2):318-20. doi: 10.1016/s0022-3476(80)80838-9.

[Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].

Arch Mal Coeur Vaiss. 1981 May;74(5):579-85.

Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.

Eur J Pediatr. 1987 May;146(3):279-82. doi: 10.1007/BF00716473.

[Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation].[前列腺素治疗依赖动脉导管循环的新生儿]

Tijdschr Kindergeneeskd. 1985 Feb;53(1):20-5.

The ductus arteriosus: why and how to manipulate its patency.动脉导管：为何以及如何控制其通畅性。

J Fla Med Assoc. 1983 Sep;70(9):788-93.

Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.用前列腺素治疗患有导管依赖性先天性心脏病的新生儿。

Pediatr Ann. 1981 Apr;10(4):29-38.

Evaluation of alprostadil (prostaglandin E1) in the management of congenital heart disease in infancy.前列地尔（前列腺素E1）用于婴儿先天性心脏病治疗的评估

Pharmacotherapy. 1982 May-Jun;2(3):148-55. doi: 10.1002/j.1875-9114.1982.tb04522.x.

Use of prostaglandin E2 in management of transposition of great arteries before balloon atrial septostomy.在球囊房间隔造口术之前使用前列腺素E2治疗大动脉转位。

Br Heart J. 1983 Apr;49(4):341-4. doi: 10.1136/hrt.49.4.341.

引用本文的文献

Keeping the Ductus Arteriosus Patent: Current Strategy and Perspectives.维持动脉导管开放：当前策略与展望

Diagnostics (Basel). 2025 Jan 21;15(3):241. doi: 10.3390/diagnostics15030241.

Balloon Atrial Septostomy: Does the Balloon Size Matter?球囊房间隔造口术：球囊大小重要吗？

CJC Pediatr Congenit Heart Dis. 2022 Oct 28;1(6):253-259. doi: 10.1016/j.cjcpc.2022.10.006. eCollection 2022 Dec.

Congenital Heart Disease Requiring Maintenance of Ductus Arteriosus in Critically Ill Newborns Admitted at a Tertiary Neonatal Intensive Care Unit.在三级新生儿重症监护病房收治的危重新生儿中，需要维持动脉导管开放的先天性心脏病

J Crit Care Med (Targu Mures). 2016 Nov 8;2(4):185-191. doi: 10.1515/jccm-2016-0031. eCollection 2016 Oct.

Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.前列腺素E1用于维持患有动脉导管依赖性心脏病变的新生儿的动脉导管通畅。

Cochrane Database Syst Rev. 2018 Feb 27;2(2):CD011417. doi: 10.1002/14651858.CD011417.pub2.

Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects.前列腺素E1：先天性心脏缺陷新生儿的第一阶段姑息治疗。

Indian J Pediatr. 1998 Mar-Apr;65(2):211-6. doi: 10.1007/BF02752297.

Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.在应用脂微球前列地尔E1治疗膈疝期间动脉导管瘤样扩张。

Eur J Pediatr. 1993 Nov;152(11):877-9. doi: 10.1007/BF01957520.

Management of cyanotic congenital heart disease with increased pulmonary blood flow.

Indian J Pediatr. 1981 Jul-Aug;48(393):457-66. doi: 10.1007/BF02822290.

Prostaglandins, ductus arteriosus, pulmonary circulation: current concepts and clinical potential.前列腺素、动脉导管、肺循环：当前概念与临床潜力

Eur J Clin Pharmacol. 1980 Jul;18(1):75-81. doi: 10.1007/BF00561482.

Use of prostaglandin E2 in management of transposition of great arteries before balloon atrial septostomy.在球囊房间隔造口术之前使用前列腺素E2治疗大动脉转位。

Br Heart J. 1983 Apr;49(4):341-4. doi: 10.1136/hrt.49.4.341.

Prostaglandin E2 administration in infants with ductus-dependent cyanotic congenital heart disease.

Eur J Pediatr. 1987 May;146(3):279-82. doi: 10.1007/BF00716473.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验